Healthcare

Tonix Pharmaceuticals Strengthens Board with Appointment of Jim Hunter

Tonix Pharmaceuticals Strengthens Board with Appointment of Jim Hunter

Tonix Pharmaceuticals Holding Corp. has appointed Jim Hunter to its Board of Directors, leveraging his commercial expertise as the company prepares for the potential launch of TNX-102 SL for fibromyalgia, marking a significant step in its growth and product development strategy.

June 13, 2025
Natalie Leek Highlights Providence House's Success in Family Reunification on NBC4

Natalie Leek Highlights Providence House's Success in Family Reunification on NBC4

Natalie Leek, CEO of Providence House, discussed the organization's impactful work in providing crisis care for children and its remarkable success in family reunification during a feature on NBC4.

June 13, 2025
Webinar to Address Innovative Approaches in Preventing Violence Against Women

Webinar to Address Innovative Approaches in Preventing Violence Against Women

Footage Foundation and El-Agartuu are set to host a webinar discussing innovative methods and research findings on preventing violence against women, highlighting the need for compassionate, evidence-based strategies to address this global issue.

June 13, 2025
Prenatal Exposure to 'Forever Chemicals' Linked to Higher Blood Pressure in Teens

Prenatal Exposure to 'Forever Chemicals' Linked to Higher Blood Pressure in Teens

New research reveals that prenatal exposure to synthetic compounds known as 'forever chemicals' is associated with higher blood pressure in children, particularly during adolescence, highlighting the need for policy-level actions to reduce exposure.

June 12, 2025
Nutriband Inc. Reports Significant Revenue Growth and Advances in AVERSA Fentanyl Development

Nutriband Inc. Reports Significant Revenue Growth and Advances in AVERSA Fentanyl Development

Nutriband Inc. showcases a 63% year-over-year revenue increase in Q1 2025 and progresses in developing AVERSA Fentanyl, aiming to introduce the first abuse-deterrent opioid patch globally.

June 12, 2025
Soligenix Inc. Advances Clinical Programs with Key Trial Results Expected by 2026

Soligenix Inc. Advances Clinical Programs with Key Trial Results Expected by 2026

Soligenix Inc. is making significant progress in its clinical programs, with critical trial results for treatments of rare diseases like cutaneous T-cell lymphoma and Behçet’s disease expected in the coming years, highlighting the company's role in addressing unmet medical needs.

June 12, 2025
Study Reveals Accelerated Biological Aging in Children with Multiple Sclerosis

Study Reveals Accelerated Biological Aging in Children with Multiple Sclerosis

New research from UC San Diego indicates that children and adolescents with multiple sclerosis experience faster biological aging, highlighting the urgent need for targeted therapies.

June 12, 2025
Scinai Immunotherapeutics Ltd. Showcases Strategic Milestones and Funding Ahead of BIO 2025

Scinai Immunotherapeutics Ltd. Showcases Strategic Milestones and Funding Ahead of BIO 2025

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) prepares for the BIO International Convention 2025, highlighting its CDMO business growth and nanobody pipeline progress, alongside securing $1.38 million in funding to support its operations without additional dilution.

June 12, 2025
GeoVax to Showcase Innovative Vaccines and Therapies at BIO International Convention 2025

GeoVax to Showcase Innovative Vaccines and Therapies at BIO International Convention 2025

GeoVax Labs, Inc. announces its participation in the 2025 BIO International Convention, highlighting its pipeline of vaccines and immunotherapies for infectious diseases and cancer, underscoring the company's role in advancing global health solutions.

June 12, 2025
Study Identifies 528 Frequency as Key to Healing and Life Extension

Study Identifies 528 Frequency as Key to Healing and Life Extension

A groundbreaking study reveals the 528Hz frequency and 528nm green light as universal constants with potential to revolutionize healing, stem cell activation, and life extension, bridging ancient wisdom with modern science.

June 12, 2025
New Study Highlights Challenges and Systemic Barriers for Liver Cancer Patients

New Study Highlights Challenges and Systemic Barriers for Liver Cancer Patients

A recent study reveals the significant hurdles faced by hepatocellular carcinoma patients, including delayed diagnoses and social stigma, calling for systemic healthcare reforms.

June 12, 2025
Wellness360 Achieves NCQA Certification for Health Appraisal and Self-Management Tools

Wellness360 Achieves NCQA Certification for Health Appraisal and Self-Management Tools

Wellness360's recent NCQA certification underscores its role in providing high-quality, data-driven wellness solutions, reflecting the growing importance of certified digital tools in enhancing employee health and organizational well-being.

June 12, 2025
Charlestown Sluggers Claim Victory in Erickson Senior Living's Annual Softball Tournament

Charlestown Sluggers Claim Victory in Erickson Senior Living's Annual Softball Tournament

The Charlestown Sluggers have secured their third consecutive championship in the Erickson Senior Living annual softball tournament, highlighting the vibrant community spirit and active lifestyle among seniors.

June 12, 2025
Lantern Pharma Advances Precision Oncology with AI-Driven Platform

Lantern Pharma Advances Precision Oncology with AI-Driven Platform

Lantern Pharma Inc. leverages its AI-driven RADR(R) platform to accelerate the development of precision cancer therapies, with three lead drug candidates in clinical trials and multiple FDA designations enhancing its regulatory pathways.

June 11, 2025
Adageis Revolutionizes Value-Based Care with AI Platform

Adageis Revolutionizes Value-Based Care with AI Platform

Adageis introduces an AI-powered platform designed to simplify value-based care for healthcare providers, enhancing revenue optimization and patient care quality.

June 11, 2025
Telomir Pharmaceuticals Reports Significant Preclinical Breakthrough with Telomir-1 in Wilson’s Disease Model

Telomir Pharmaceuticals Reports Significant Preclinical Breakthrough with Telomir-1 in Wilson’s Disease Model

Telomir Pharmaceuticals' preclinical data reveals Telomir-1's potential to reverse symptoms of Wilson’s disease, a rare copper accumulation disorder, marking a significant step towards human trials and offering hope for patients.

June 11, 2025
GeoVax Advances Mpox Vaccine Development Amid WHO's Global Health Emergency Declaration

GeoVax Advances Mpox Vaccine Development Amid WHO's Global Health Emergency Declaration

GeoVax Labs, Inc. is responding to the WHO's declaration of Mpox as a global public health emergency by advancing its GEO-MVA vaccine, aiming to address the urgent need for diversified vaccine supply and enhanced pandemic preparedness.

June 11, 2025
Kamada Reports Strong Q1 2025 Growth and Expands Plasma Business

Kamada Reports Strong Q1 2025 Growth and Expands Plasma Business

Kamada Ltd. showcases significant first-quarter growth with a 17% increase in revenue and 54% rise in Adjusted EBITDA, alongside strategic expansions in its plasma business and international deals.

June 11, 2025
Lifordi Immunotherapeutics Unveils Promising Preclinical Data for LFD-200 at EULAR 2025

Lifordi Immunotherapeutics Unveils Promising Preclinical Data for LFD-200 at EULAR 2025

Lifordi Immunotherapeutics has presented preclinical data on LFD-200, a novel antibody-drug conjugate targeting autoimmune and inflammatory diseases, showing efficacy without systemic toxicity, marking a potential breakthrough in treatment options.

June 11, 2025
Mothers’ Milk Bank California Introduces Flexible Donation Options to Support Medically Fragile Babies

Mothers’ Milk Bank California Introduces Flexible Donation Options to Support Medically Fragile Babies

Mothers’ Milk Bank California is offering flexible milk pick-up services and Saturday screening appointments to encourage breast milk donations during the summer, addressing a critical need for medically fragile infants.

June 11, 2025
American Heart Association Launches Data Challenge to Uncover Inflammation's Role in Heart Disease

American Heart Association Launches Data Challenge to Uncover Inflammation's Role in Heart Disease

The American Heart Association has initiated the Systemic Inflammation Data Challenge to explore the connection between inflammation, marked by elevated hsCRP levels, and cardiovascular disease, aiming to improve health outcomes through advanced data science.

June 11, 2025
Denver's Exchange at Boulevard One Hosts Summer Events to Foster Community and Wellness

Denver's Exchange at Boulevard One Hosts Summer Events to Foster Community and Wellness

The Exchange at Boulevard One in Denver launches Namaste Nights and the Boulevard One Farmers Market, offering unique opportunities for community engagement, wellness, and local shopping.

June 11, 2025
Artemis Adolescent Healing Center Launches Comprehensive Teen Mental Health Programs in Arizona

Artemis Adolescent Healing Center Launches Comprehensive Teen Mental Health Programs in Arizona

The Artemis Adolescent Healing Center in Arizona has officially opened its doors, offering specialized mental health treatment programs for adolescents, addressing a critical need for accessible and personalized care in the region.

June 11, 2025
HIGHER Corporation Recognized as 'Baby Unicorn' for Innovative Medical Devices

HIGHER Corporation Recognized as 'Baby Unicorn' for Innovative Medical Devices

HIGHER Corporation's selection as a 'Baby Unicorn' underscores its potential in the global medical device market, with its HILO WAVE® product leading the charge in innovative skin regeneration technology.

June 11, 2025
The Complex Decision of When Seniors Should Stop Driving

The Complex Decision of When Seniors Should Stop Driving

Frances Fuller, author of 'Helping Yourself Grow Old', explores the emotional and practical challenges seniors face when deciding to stop driving, highlighting the broader implications for independence and safety in aging populations.

June 11, 2025
Creative Biolabs Advances Microbiome-Based Drug Development with Enhanced LBP Analytics

Creative Biolabs Advances Microbiome-Based Drug Development with Enhanced LBP Analytics

Creative Biolabs has introduced an advanced microbial service platform to streamline the development of microbiome-based drugs, addressing key challenges in strain characterization, contaminant detection, and formulation stability.

June 11, 2025
Award-Winning Documentary 'Where the Horses Heal the Soul' to Screen in Austin, Supporting Equine Assisted Services

Award-Winning Documentary 'Where the Horses Heal the Soul' to Screen in Austin, Supporting Equine Assisted Services

The documentary highlights the transformative power of equine assisted services for individuals facing physical and emotional challenges, showcasing stories of veterans, a teenager with Down syndrome, and a young woman with cerebral palsy.

June 11, 2025
VERAXA Biotech AG and Voyager Acquisition Corp. Announce $1.64 Billion Merger to Advance Cancer Therapies

VERAXA Biotech AG and Voyager Acquisition Corp. Announce $1.64 Billion Merger to Advance Cancer Therapies

VERAXA Biotech AG and Voyager Acquisition Corp. have agreed to a $1.64 billion merger, aiming to accelerate the development of innovative cancer therapies through VERAXA's Bi-Targeted Antibody Cytotoxicity platform.

June 10, 2025
Calidi Biotherapeutics Appoints Biotech Veteran Eric Poma as CEO to Drive Growth

Calidi Biotherapeutics Appoints Biotech Veteran Eric Poma as CEO to Drive Growth

Calidi Biotherapeutics Inc. has named Eric Poma, PhD, as its new CEO and board member, marking a strategic step to advance its innovative cancer therapies towards commercialization.

June 10, 2025
Pacylex Pharmaceuticals Showcases Promising NMT Inhibitors at BIO Annual Meeting

Pacylex Pharmaceuticals Showcases Promising NMT Inhibitors at BIO Annual Meeting

Pacylex Pharmaceuticals Inc. highlights its innovative N-myristoyltransferase inhibitors (NMTis) at the BIO International Convention, showcasing potential breakthroughs in cancer treatment through oral zelenirstat and ADC payloads.

June 10, 2025
PreviousPage 62 of 80Next